menu search

Steven madden: a shoe-in candidate for your portfolio

Steven Madden continues to post sales increases, but the most recent data available shows some weakness on the bottom line. While this may be disappoi...

January 25, 2023, 10:12 am

Howard’s announces promotion of matt horwitz to senior vice president, chief revenue officer

Independent retailer continues strengthening its executive team with internal candidate LA HABRA, Calif...

January 24, 2023, 9:51 pm

Defense in an uncertain world: sell lockheed martin, buy hii?

Lockheed Martin, for example through its F-35 franchise, has seen interest in its services due to the war in Ukraine and Europe's increasing emphasis ...

January 24, 2023, 5:53 pm

Nvidia outlook improving: watchlist candidate for 2023

NVIDIA Corporation (NASDAQ: NVDA) was one of the many chipmaker stocks that struggled through 2022. Not only did this stock drop as much as 70%, but i...

January 24, 2023, 3:00 am

Is a giant short squeeze brewing in wayfair (w) stock?

Wayfair (NYSE: W ) stock is on the move Monday and it could be investors preparing for a short squeeze of the e-commerce company's shares. Investors w...

January 23, 2023, 11:59 am

Enovix: short-term hiccups provide significant upside for patient long-term investors

A timely candid presentation laid the roadmap for production and commercialization as well as increased...

January 23, 2023, 12:26 am

2 best stocks to own for passive income in 2023

An analysis by S&P Global says that these two stocks are prime candidates to significantly raise divide...

January 22, 2023, 7:10 am

Mindset pharma receives allowance for us patent application covering lead psychedelic therapeutic candidate

Mindset Pharma Inc (CSE:MSET, OTCQB:MSSTF) told investors that the US Patent and Trademark Office (USPTO) has granted allowance for its patent applica...

January 20, 2023, 7:49 am

Vertex energy: a short-squeeze candidate

Vertex had a challenging 2022, as management messed-up the crack spread hedging. In Q4'22 the hedges are off, allowing Vertex to get full exposure to ...

January 19, 2023, 11:18 pm

Mineralys therapeutics builds on phase 2 trial success with ipo filing

Mineralys Therapeutics has filed to raise drug candidate development funding via a U.S. IPO. The firm i...

January 19, 2023, 10:45 pm

Horizon (hznp) dazodalibep meets goal in sjogren's syndrome study

Horizon Therapeutics (HZNP) announces that a phase II Sjogren's syndrome study of its candidate, dazoda...

January 19, 2023, 3:03 pm

Ubs: curevac has a ‘potentially competitive mrna platform'

CureVac's CVAC, +8.44% promising Phase 1 data for flu and COVID-19 vaccine candidates is a signal to in...

January 19, 2023, 1:56 pm

J&j (jnj) discontinues hiv vaccine phase iii mosaico study

J&J (JNJ) discontinues phase III study on its investigational HIV vaccine regimen, which shows that the candid...

January 19, 2023, 9:02 am

Marvell technology: fade the cfo reshuffle

Marvell's CFO departs; as she will be replaced by an internal candidate, though, the outcome is likely ...

January 19, 2023, 4:18 am

7 biotech stocks that will make you rich in 10 years

If you have the patience to go through wild undulations, then you may be a candidate for biotech stocks...

January 18, 2023, 3:44 pm

Angion (angn) down on merger agreement with private biotech

Angion (ANGN) inks a definitive merger agreement with privately-held Elicio Therapeutics. The combined company's lead pipeline ...

January 18, 2023, 2:18 pm

Call on kbnd for china bond market opportunity

Emerging markets bonds languished in 2022 as the U.S. dollar and interest rates soared, but the asset class is seen as a potential rebound ...

January 18, 2023, 8:58 am

Tesla's elon musk is smart and a genius but 'a little off his rocker', prospective jurors in the 'funding secured' trial say

The jury candidates were grilled for impartiality in the trial over whether Musk cheated investors by t...

January 18, 2023, 8:18 am

Fsd pharma submits clinical trial application for its multiple sclerosis treatment candidate lucid-ms

FSD Pharma Inc (CSE:HUGE, NASDAQ:HUGE) announced it has submitted a Clinical Trial Application (CTA) for a planned Phase-1 clinical trial for Lucid-MS...

January 17, 2023, 10:12 am

Kweb credible comeback candidate for 2023

After spending nearly two years tumbling due to Beijing's crackdown on consumer internet and online education firms, among others, the KraneShares CSI...

January 17, 2023, 8:26 am


Search within

Pages Search Results: